{Reference Type}: Journal Article
{Title}: Advances in Endocrine Surgery.
{Author}: Lui MS;Shirali AS;Huang BL;Fisher SB;Perrier ND;
{Journal}: Surg Oncol Clin N Am
{Volume}: 32
{Issue}: 1
{Year}: 01 2023
{Factor}: 2.402
{DOI}: 10.1016/j.soc.2022.08.004
{Abstract}: Recent changes in the landscape of endocrine surgery include a shift from total thyroidectomy for almost all patients with papillary thyroid cancer to the incorporation of thyroid lobectomy for well-selected patients with low-risk disease; minimally invasive parathyroidectomy with, and potentially without, intraoperative parathyroid hormone monitoring for patients with well-localized primary hyperparathyroidism; improvement in the management of parathyroid cancer with the incorporation of immune checkpoint blockade and/or targeted therapies; and the incorporation of minimally invasive techniques in the management of patients with benign tumors and selected secondary malignancies of the adrenal gland.